LMS risk management tool, CALM Patterns, to receive European CE Mark clearance
September 27 2005 - 9:30AM
PR Newswire (US)
MONTREAL, QC, Sept. 27 /PRNewswire-FirstCall/ -- LMS Medical
Systems (AMEX:LMZAMEX:TSX:AMEX:LMZ), a healthcare technology
company and developer of the CALM(TM) system (Computer Assisted
Labor Management), is pleased to announce having received notice
that CALM Patterns, its obstetrical risk management software tool,
is included under the current CALM CE Mark. Commercial availability
of CALM Patterns, which has recently received clearance from the
United States FDA, is scheduled for early 2006. CALM Patterns is
one is a series of proprietary risk management tools based on
probabilistic models that are designed to provide clinicians with
an objective real-time bedside means to more clearly and accurately
assess clinical conditions, improve situational awareness and
reduce risk. CALM Patterns contains specialized algorithms and
neural networks that detect and measure patterns in fetal heart
rate recordings. These events are interpreted using rule-based
systems to consistently and better identify the fetus at risk for
brain injury from oxygen deprivation. CALM Patterns forms a suite
of tools with CALM Curve, presently available, and CALM Shoulder
Screen, which will be commercially available in the fall of 2005.
"This clearance enables LMS to extend the reach of the full suite
of CALM risk management solutions into additional geographic
territories," stated LMS President and Chief Executive, Diane Cote.
"With similar obstetrical challenges being experienced across
Europe we now have the opportunity to start building an
international presence for our solutions." About LMS: LMS Medical
Systems is a leader in the application of advanced mathematical
modeling and neural networks for medical use. The LMS Computer
Assisted Labor Management product suite provides physicians,
nursing staff and risk managers with innovative obstetrical
decision support and risk management tools integrated into robust
clinical information systems designed to improve outcomes and
patient care for mothers and their infants during labor and
delivery. This press release contains forward-looking statements
that involve risks and uncertainties, which may cause actual
results to differ materially from the statements made. For this
purpose, any statements that are contained herein that are not
statements of historical fact may be deemed to be forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Without limiting
the foregoing, the words "believes," "anticipates," "plans,"
"intends," "will," "should," "expects," "projects," and similar
expressions are intended to identify forward-looking statements.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause actual results, future
circumstances, or events to differ materially from those projected
in the forward-looking statements. These risks include, but are not
limited to, those associated with the success of research and
development programs, the adequacy, timing, and results of clinical
trials, the regulatory approval process, competition, securing and
maintaining corporate alliances, market acceptance of the Company's
products, the strength of intellectual property, financing
capability, the potential dilutive effects of any financing,
reliance on subcontractors and key personnel, and other risks
detailed from time-to-time in the Company's public disclosure
documents or other filings with the Canadian and U.S. securities
commissions or other securities regulatory bodies. The
forward-looking statements are made as of the date hereof, and the
Company disclaims any intention and has no obligation or
responsibility, except as required by law, to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise. DATASOURCE: LMS MEDICAL SYSTEMS INC.
CONTACT: please contact: Andrea Miller, Communications, LMS Medical
Systems Inc., (514) 488-3461 Ext. 222, Fax: (514) 488-1880, E-mail
; Website: http://www.lmsmedical.com/
Copyright
Bank of America Corp. Capped Leveraged Index Return Note Linked TO The S&P 500 (AMEX:LMZ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bank of America Corp. Capped Leveraged Index Return Note Linked TO The S&P 500 (AMEX:LMZ)
Historical Stock Chart
From Jul 2023 to Jul 2024